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Abstract
Background: The risk of postnatal HIV transmission is associated with the magnitude of the milk virus load. While HIV-
specific cellular immune responses control systemic virus load and are detectable in milk, the contribution of these
responses to the control of virus load in milk is unknown.
Methods: We assessed the magnitude of the immunodominant GagRY11 and subdominant EnvKY9-specific CD8+ T
lymphocyte response in blood and milk of 10 A*3002+, HIV-infected Malawian women throughout the period of lactation
and correlated this response to milk virus RNA load and markers of breast inflammation.
Results: The magnitude and kinetics of the HIV-specific CD8+ T lymphocyte responses were discordant in blood and milk of
the right and left breast, indicating independent regulation of these responses in each breast. However, there was no
correlation between the magnitude of the HIV-specific CD8+ T lymphocyte response and the milk virus RNA load. Further,
there was no correlation between the magnitude of this response and markers of breast inflammation.
Conclusions: The magnitude of the HIV-specific CD8+ T lymphocyte response in milk does not appear to be solely
determined by the milk virus RNA load and is likely only one of the factors contributing to maintenance of low virus load in
milk.
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Introduction
HIV transmission via breastfeeding remains a major mode of
infant HIV acquisition, accounting for nearly half of the 350,000
infant HIV infections occurring annually [1,2]. In the absence of
antiretroviral prophylaxis, only a small minority of HIV-infected
mothers transmit the virus via breastfeeding despite chronic low
dose virus exposure [2–4]. This low rate of virus transmission
suggests immune protection of the majority of infants from virus
acquisition during breastfeeding. The risk of breastfeeding
transmission of HIV has been linked to the magnitude of both
the virus DNA and RNA load in milk [5–7]. Furthermore, recent
phylogenetic studies of the milk virus population suggest that
transient local replication of virus partially contributes to the pool
of virus in milk [8–11]. Therefore, immune containment of local
virus replication in the breast may contribute to protection against
virus transmission via breastfeeding.
HIV/SIV-specific CD8+ T lymphocytes are critical in control
of systemic virus replication [12–15]. While HIV/SIV-specific
CD8+ T lymphocytes have been identified and characterized in
mucosal compartments [16–22], including breast milk [23,24], the
role of this response in the containment of mucosal virus
replication is unclear. Interestingly, milk virus RNA load remains
one to two logs lower than the systemic virus load throughout
infection [24–26]. The maintenance of low virus load in the setting
of a robust virus-specific CD8+ T lymphocyte response in milk
suggests that this response may contribute to control of milk virus
replication. In fact, virus-specific CD8+ T lymphocyte responses
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with the decline of milk virus RNA load following acute infection
[24]. Moreover, studies of highly HIV-exposed, uninfected sub-
jects suggest that HIV-specific cellular responses in the genital
tract contribute to protection against virus acquisition [27].
Defining of the role of mucosal virus-specific CD8+ T lymphocytes
in containment of local virus replication and transmission is crucial
for guidance of HIV vaccine design.
We sought to establish the relationship between the kinetics of the
milk HIV-specific CD8+ T lymphocyte responses and virus RNA
load by longitudinal assessment of milk of chronically HIV-infected,
lactating women. Furthermore, states of breast inflammation,
including mastitis [6,28–32], and elevated levels of certain cytokines
in milk have been associated with increased milk HIV load [32–34]
and the risk of HIV transmission via breastfeeding. Therefore, we
sought to define the relationship between breast inflammation and
the HIV-specific CD8+ T lymphocyte response to better understand
how breast inflammation leads to increased risk of HIV transmission.
Methods
Ethics statement
This study was approved by the Division of Aquired
Immunodeficiency Syndrome, National Institute of Allergy and
Infectious Diseases, National Institute of Health (DAIDS-ES ID
10491); the College of Medicine Research and Ethics Committee
in Malawi (P.06/06/440); and institutional review boards at each
participating institutions, including University of North Carolina
(07–0831), Duke University (Pro00003582), and Beth Israel
Deaconess Medical Center (2006_P_000199). Written consent
was obtained from all subjects.
The primate studies were approved by the Harvard IACUC and
in accordance with the recommendations of the Weatherall Report.
Animals were maintained in accordance with the guidelines of the
Committee on Animals for the Harvard Medical School, the ‘‘Guide
for the Care and Use of Laboratory Animals’’ (National Research
Council, National Academic Press, Washington, D.C., 1996), and
the United States Department of Agriculture Animal Welfare Act.
Blood parameters were monitored for SIV disease progression and
humane euthanasia was performed once disease progression was
noted. All non-human primates receive environmental enrichment
including foraging and opportunity to exhibit species-specific
behavior. Animals are pair or group housed when possible.
Subjects and HLA typing
HIV-infected, lacating Malawian women providing written
informed consent were enrolled at delivery as previously described
[35]. Blood and milk from each breast were collected within 3 days
after delivery, 4 weeks after delivery, and every 12 weeks until
cessation of breastfeeding. Nine uninfected mothers within 4 weeks
of delivery were recruited from the same clinics for a single milk
and blood donation as an uninfected control group. PBMCs were
isolated by Ficoll centrifugation and milk cells were isolated by
centrifugation [24] and stored in 10% DMSO-containing media
and frozen in liquid nitrogen.
All 77 mothers enrolled were HLA typed by the sequence-
specific primer method on DNA extracted from PBMCs or B-LCL
lines made by Epstein barr virus transformation of PBMCs. This
method, adapted from Bunce [36], provides absolute HLA
resolution in two digits and high-probability resolution to four
digits. The 10 women selected for this study had MHC class I
allele A*3002 and remained off antiretroviral therapy (except
single dose nevirapine at delivery), facilitating longitudinal analysis
of virus load in the absence of therapy. Nine of the 10 subjects
selected had samples from two time points available. None of these
women transmitted HIV to their infant postnatally (defined by
positive infant HIV DNA at .4 weeks of age).
Animals
Three Mamu A*01+, simian immunodeficiency virus (SIV)-
infected lactating rhesus monkeys (four months after inoculation
[24]) were also used in this study to validate MHC-restricted
immunodominant epitope tetramer staining in cryopreserved milk
cells (Fig S1).
Single genome amplification and sequencing of the
A*3002-restricted GagRY11 and EnvKY9 epitopes
RNA was extracted and converted to cDNA from maternal
plasma aliquots from the screening visit containing approximately
10,000 viral RNA copies as previously described [35] using the
primer Gag OR (59-GTAACCTATCCCATTCTGCAGCTTC-
CTC-39) or Env OR (59-TATGGGATCAAAGCCTAAAGC-
CATG-39). The genes were PCR amplified by single genome
amplification methods [37]. PCR primers for the first round
included: Gag OF (59-GCGAGAGCGTCAGTATTAAGCGGG-
39) and Env OF (59-TATGGGATCAAAGCCTAAAGCCATG-
39) and the respective cDNA primers. Second-round PCR primers
were: Gag IF (59-GGCCAGGGGGAAAGAAAAAATATAGAC-
39), Gag IR (59-GTGGGGGTGGCTCCTTCTGATAATGC-
39); and Env IF (59-CCTCAGCCATAACACACAAGCCTGTC-
39), Env IR (59-CTGCCAATCAGGGAAGTAGCCTTGTGT-
39). Amplicons resulting from cDNA dilutions yielding less than
30% PCR positivity were sequenced to identify variants with
anchor residue mutations in the HLA A* 3002-restricted
GagRY11 and EnvKY9 epitopes, previously defined by Goulder,
et al [38].
HLA A*3002 HIV epitope-specific tetramer production
E. coli transformed with the HLA A*3002 plasmid was provided
by the NIH Tetramer Core Facility. The resulting protein was
harvested, folded with b2 microglobulin and GagRY11 or
EnvKY9 peptides, and tetramerized as previously described
[39]. Tetramers were fluorescently labeled and specificity was
confirmed by flow cytometry (Fig 1).
Tetramer staining and flow cytometric analysis
Cryopreserved PBMCs and milk cells were thawed and
incubated for 15 min at 37uC in 50 nM dasatinib (LC Labora-
tories), a protein kinase inhibitor which prevents T cell receptor
down-regulation. Cells were stained with the HLA A*3002
GagRY11-phycoerythrin and EnvFK9- allophycocyanin tetramer
and the following phenotyping antibodies: anti-CD3-Pacific Blue
(SP34.2; Becton Dickinson), anti-CD4-QDot 655 (19Thy5D7),
anti-CD8-QDot605 (7pt3F9), anti-CD28-ECD (CD28.2; Beck-
man Coulter), and anti-CD95-phycoerythrin-cyanine 7 (DX2;
Becton Dickinson). Naı ¨ve and memory lymphocyte subsets were
defined by anti-CD95 and anti-CD28 staining (naı ¨ve: CD28
+,
CD95
2; effector memory: CD28
2, CD95
+; central memory:
CD28
+, CD95
+) [40,41]. Amine dye (Molecular Probes) staining
was used to distinguish live from dead cells. The viable CD3+ T
cell number in the milk samples identified by flow cytometry
ranged between 200 and 12,000 cells (median: 1605 viable CD3+
T cells). This viable lymphocyte number after cryopreservation
represents approximately 30% of the median original lymphocyte
number recovered from an ounce of fresh milk in preliminary
studies (5610
4 viable CD3+ T cells, range: 3610
4 –8610
5).
Samples with less than 200 viable CD3+ T cells were excluded
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cells collected 4 days apart from SIV-infected monkeys were
stained with the above antibodies and Mamu A*01-restricted
Gagp11C epitope tetramer [24]. The proportion of Gagp11C-
specific CD8+ T lymphocytes was remarkably similar in the fresh
cells and cryopreserved/thawed cells, despite loss in cell viability
after cryopreservation (Fig S1). Gating strategy was as follows:
lymphocyte population on forward scatter vs. side scatter plot;
CD3+ viable cells on CD3 vs. amine dye plot; CD8+CD4- cells on
plot of CD4 vs. CD8; tetramer+CD8+ cells on plot of tetramer vs.
CD8.
HIV plasma and milk virus RNA load
Virus RNA loads were quantified using the Roche COBAS
Ampliprep/COBAS Taqman 48 for HIV-1 viral load assay as
previously described [35]. The minimum of detection in the assay
was 48 copies, therefore, samples with detectable virus load below
the minimum of detection are indicated as ,48 copies. Plasma was
diluted 1:10 and milk was diluted 1:5 before performing the assay.
Sodium:Potassium Ratio
The sodium:potassium ratio of milk supernatant was measured
using the Gen2 Ion Selective Electrode on the Roche Cobias c501
platform (Roche Diagnostics). A sodium:potassium ratio .1i s
used as an indicator of mastitis [28,31,42].
Cytokine concentrations in milk
The concentrations of IL-7 and IL-8 in milk were quantified
using a high-sensitivity human cytokine Lincoplex kit (Millipore)
and RANTES was measured by Bio-Plex cytokine assay (Bio-
Rad). Each sample was diluted 4-fold and assayed in duplicate.
Data were acquired on a Luminex-100 system and analysed using
Bio-Plex Manager software, v4.1 (Bio-Rad). IL-15 was quantitated
using a high-sensitivity chemiluminescent ELISA (R&D Systems).
Samples were diluted 2-fold and run in duplicate.
Statistical Analysis
The phenotypes of T lymphocyte populations were compared
by the Mann Whitney U test. The magnitudes of the HIV-specific
CD8+ T lymphocyte responses were compared by the paired
Wilcoxon’s sign rank test. Correlations were performed using
Spearman’s rank correlation test (using log values for virus load),
all with Prism 5 software. For comparisons with virus RNA load,
the minimum of detection, after taking into account the sample
dilution (240 copies for milk and 480 copies for plasma), was
assigned to samples with detectable virus load that was below the
minimum of detection, whereas the value half way between the
minimum of detection and zero was assigned to samples with
nondetectable virus load.
Results
Phenotype of T lymphocytes in milk of HIV-infected and
uninfected lactating women
We performed phenotypic analysis of the CD4+ and CD8+ T
lymphocyte populations in blood and milk of HIV-infected (n=9)
and uninfected (n=9) lactating Malawian women collected 4
weeks after delivery. The median proportion of CD4+ T
lymphocytes in milk was significantly lower in HIV-infected
women than uninfected women (17% vs. 52%, p=0.002). The
median proportion of central memory CD4+ T lymphocytes was
significantly higher in milk of HIV-infected mothers than
uninfected mothers (94% vs 70%, p=0.002), whereas the median
proportions of both naı ¨ve (0.8% vs 9%, p,0.001) and effector
memory (5% vs 14%, p=0.02) CD4+ T lymphocytes were
significantly lower in milk of HIV-infected mothers. Furthermore,
the median proportion of naive CD8+ T lymphocytes was
significantly lower in milk of HIV-infected women than that of
uninfected women (0.2% vs 4%, p,0.001) (Table 1).
Assessment of cytotoxic T lymphocyte (CTL) escape
mutations in the GagRY11 and EnvKY9 epitopes
To accurately evaluate themagnitudeof the HIVepitope-specific
CD8+ T lymphocyte responses and the relationship to milk virus
RNAload,wefirstassessedtheextent ofCTLescapeattheA*3002-
restricted GagRY11 and EnvKY9 epitopes, previously defined as
immunodominant and subdominant HIV-specific responses in this
haplotype by Goulder et al [38]. This analysis was performed on
plasma, as milk virus RNA load was not high enough to obtain
single amplicons in all subjects. CTL escape was defined as an
amino acid mutation of a defined anchor residue in the epitope
peptide[38].Notsurprisingly,CTLescapeattheimmunodominant
GagRY11 epitope was detected in over half of subjects, whereas
mutations in the subdominant EnvKY9 epitope were less frequent
(Table 2). Importantly, there was an inverse correlation between the
proportion of plasma virus variants with CTL escape mutations in
Figure 1. Detection of HLA A*3002-restricted virus-specific CD8+ T lymphocyte responses in blood and milk. Identification of
GagRY11-specific cells in the CD8+ T lymphocyte population in blood and milk of an HIV-infected, A*3002+ lactating woman (A and B), but not in the
milk CD4+ T lymphocyte population of the same subject (C), or in the peripheral blood CD8+ T lymphocyte population of an uninfected, A*3002+
subject (D), or an HIV-infected, A*3002- subject.
doi:10.1371/journal.pone.0023735.g001
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lymphocyte response in blood (r=20.48, p=0.04) and a similar
trend with that in mature milk (r=20.42, p=0.06). There was also
a trend towards an indirect correlation between the magnitude of
the plasma or milk virus RNA load at four weeks after delivery and
the proportion of GagRY11 escape virus variants in plasma
(r=20.53, p=0.12 and r=20.58, p=0.09).
Robust HIV epitope-specific CD8+ T lymphocyte
responses in milk
The magnitudes of the HIV epitope-specific CD8+ T
lymphocyte responses in blood and milk of 10 A*3002+, HIV-
infected women were assessed by tetramer staining (Fig.1A and B).
To address nonspecific staining and background flow cytometric
events in milk samples with limited cell number, we assessed the
proportion of events appearing in the tetramer-positive quadrant
in a cell population that should not bind to the tetramer, the milk
CD4+ T lymphocyte population (Fig. 1C). Furthermore, we
assessed the background tetramer staining of the CD8+ T
lymphocyte population in PBMCs of an A*3002+, uninfected
subject (Fig. 1D) and an A*3002-, HIV-infected subject (Fig. 1D
and E). In these all of these analyses, there were only one to three
positive events in the tetramer quadrant of the plot (,0.04%)
(Fig. 1C – E).
Table 1. The phenotype of CD4+ and CD8+ T lymphocytes in milk of HIV-infected and uninfected Malawian women.
HIV-infected (n=10) Uninfected (n=9) P value
1
Median proportion (range) Median proportion (range) Median proportion (range)
Peripheral blood % CD4+ T cells 41.2 (21.3 – 61.6) 68 (57.4 – 83.4) 0.008
Breast milk % CD4+ T cells 16.9 (3.9 – 39.7) 52.35 (0.9 – 67.4) 0.0002
Peripheral blood % CD8+ T cells 41.3 (31.1 – 72.1) 20.7 (13.3 – 31.6) ,0.0001
Breast milk % CD8+ T cells 76.9 (50.7 – 93.6) 34.2 (20.2 – 89.4) 0.0002
Breast milk % CD4+ effector memory T cells 4.8 (0 – 46.6) 14.2 (0 – 31.6) 0.02
Breast milk % CD4+ central memory T cells 93.6 (51.6 – 100) 70.4 (36.9 – 86.5) 0.0002
Breast milk % CD4+ naı ¨ve T cells 0.8 (0 – 15.8) 8.7 (1.3 – 46.1) ,0.0001
Breast milk % CD8+ effector memory T cells 75.1 (40.6 – 92.6) 70.9 (39.3 – 98.6) 0.97
Breast milk % CD8+ central memory T cells 23.4 (6.2 – 55.2) 20.3 (0.8 – 42.2) 0.18
Breast milk % CD8+ naı ¨ve T cells 0.24 (0 – 4.2) 4.4 (0.4 – 43.6) ,0.0001
1Comparison between HIV-infected and uninfected, bolded P values are considered significant differences (,0.05).
2Breast milk cell values include T lymphocyte subset proportions in milk of R and L breast for each subject.
doi:10.1371/journal.pone.0023735.t001
Table 2. The CD4 count, virus load, and proportion of plasma virus variants with CTL-escape at the HLA A*3002-restricted
immunodominant GagRY11 and subdominant EnvKY9 epitopes in HIV-infected, A*3002+, lactating Malawian women.
Subject
ID
Peripheral
CD4+ Tc e l l
count
1
cells/ml
Plasma virus
load
2
copies/ml
Milk virus
load left (right)
2
copies/ml
Number of CTL-escaped
plasma virus variants/
number of variants
sequenced (proportion)
GagRY11 CTL-
escaped
virus variants.Wild
type:
RSLYNTVATLY
3
EnvKY9 CTL-
escaped virus
variants.
Wild type:
KYLGSLVQY
Gag RY11 Env KY9
0406 584 2,840 ND
4 (ND) 5/5 (100%) 0/14 (0%) RSLYNTVATLC
5
1503 344 3.890 4,295 (1700) 0/19 (0%) 1/15 (6.7%) KYLGSLVQC
2007 491 11,300 ND (ND) 1/22 (4.5%) 0/20 (0%) KSLFNTVATLC
2401 400 ,48
6 ND (ND) 13/15 (86.7%) 0/8 (0%) RSLYNTVATLC
3706 385 11,000 ND (340) 12/18 (66.7%) 0/20 (0%) RSLFNTIATLF
3808 267 27,400 9,900 (17,800) 0/28 (0%) 7/21 (33.3%) - KYLGGLVQN
3902 213 19,900 28,950 (27,500) 8/16 (50%) 3/16 (18.8%) RSLYNTVATLC KHLGSLVQY
5506 420 538 ,48 (ND) 1/4 (25%) 0/4 (0%) KSLFNTVATLC
6703 395 4,900 ,48 (ND) 0/22 (0%) 0/15 (0%)
6905 434 37,900 ,48 (326) 0/15 (0%) 0/19 (0%)
1CD4+ T cell count performed in third trimester of pregnancy.
2Plasma and milk virus load reported from samples collected at 4–6 weeks after delivery.
3Anchor residues in bold italics [38].
4ND = not detected.
5Anchor residue mutations are indicated in bold.
6,48 copies indicates detection of HIV RNA at a level below the minimum quantitative standard control in this assay.
doi:10.1371/journal.pone.0023735.t002
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responses were compared between blood and milk of HIV-infected
women. The proportion of epitope-specific CD8+ T lymphocytes
from each sample collected from the same subject were averaged
to improve the accuracy of this comparison. The median
magnitude of the aggregate proportion of GagRY11 and
EnvKY9-specific CD8+ T lymphocytes was significantly higher
in milk than blood of our subjects (GagRY11: 0.85% v 0.33%;
p=0.01; EnvKY9: 0.09% vs 0.007%; p=0.02) (Fig. 2A and D). In
contrast, there was no detectable difference between the responses
in milk of the left and right breast of our subjects in paired
comparisons (Fig. 2B and E). Furthermore, the median magnitude
of the immunodominant CD8+ T lymphocyte response in
colostrum (0.34%) and mature milk (collected at 4 or 12 weeks
after delivery)(0.6%) from each breast were similar in paired
comparisons (p=0.73) (Fig. 2C). However, the median magnitude
of the subdominant EnvKY9 CD8+ T lymphocyte response was
significantly higher in mature milk (0.04%) than colostrum (0%;
p=0.02) (Fig. 2F).
HIV epitope-specific CD8+ T lymphocyte response in milk
is discordant with that in blood and the contralateral
breast
We next compared the kinetics of the HIV-specific CD8+ T
lymphocyte response in blood and milk of each breast (Fig. 3 and
4). Notably, the kinetics of both the GagRY11 and EnvKY9-
specific CD8+ T lymphocyte response was discordant in blood and
milk throughout lactation in subjects both with considerable CTL
escape of their plasma virus population and those without evidence
of CTL escape of the plasma virus population. Increases in the
magnitude of the response in blood or milk were not typically
mirrored by concurrent increases in the other compartments. In
fact, only subject 2007 displayed kinetics of the GagRY11-specific
CD8+ T lymphocyte response in milk that mirrored that in blood.
Furthermore, the kinetics of the HIV-specific CD8+ T lymphocyte
responses were discordant between the left and right breasts in the
majority of subjects (Fig. 3 and 4). Importantly, the median
proportion of central and effector memory CD8+ T lymphocytes
did not change significantly over time in milk of these HIV-
infected subjects (data not shown).
No consistent relationship between the magnitude of
the HIV-specific CD8+ T lymphocyte response and virus
RNA load in milk
As the magnitudes and kinetics of the HIV-specific CD8+ T
lymphocyte response in blood and milk of each breast were
discordant, we hypothesized that this response is driven by the
level of virus replication in each breast. In fact, it is well-established
that milk virus load varies between breasts [43]. Moreover, several
groups have reported clonal amplification of virus variants in milk
[8,9,11,35], likely reflecting transient local virus replication in the
breast. We compared the magnitude and kinetics of the HIV-
specific CD8+ T lymphocyte responses to that of the milk virus
RNA load. Overall, there was no consistent relationship between
the magnitude or kinetics of the GagRY11 or EnvKY9-specific
CD8+ T lymphocyte responses and the milk virus RNA load
(Fig. 4). The kinetics of the GagRY11-specific CD8+ T lympho-
cyte response tracked together with the milk virus RNA load
(subject 3706, right breast; and subject 1503, right breast). The
EnvKY9-specific CD8+ T lymphocyte response mirrored the
Figure 2. High magnitude HIV-specific CD8+ T lymphocyte responses in milk. The mean immunodominant GagRY11-specific (A) and
subdominant EnvKY9-specific (D) CD8+ T lymphocyte response blood and milk of 10 HIV-infected, lactating women. The GagRY11-specific (B and C)
and EnvKY9-specific (E and F) CD8+ T lymphocyte responses in the left and right breast and colostrum and mature milk. Line indicates the median of
the responses among all subjects, p values #0.05 are indicated.
doi:10.1371/journal.pone.0023735.g002
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6703 (left breast). However, no consistent relationship between the
milk virus RNA load and HIV-specific CD8+ T lymphocyte
responses was discernable in the remaining subjects. Finally, there
was no correlation between the milk virus RNA load and the
magnitude of the GagRY11-specific CD8+ T lymphocyte response
in colostrum (r=0.043, p=0.85) or mature milk (r=0.14,
p=0.57) of each breast. While there was also no correlation
between the milk virus RNA load and the magnitude of the
EnvKY9-specific CD8+ T lymphocyte response in mature milk
(r=0.29, p=0.24), there was a significant direct correlation
between the milk virus RNA load and the magnitude of the
EnvKY9-specific CD8+ T lymphocyte response in colostrum
(r=0.57; p=0.009). We did not identify an inverse correlation
between the magnitude of the HIV-specific CD8+ T lymphocyte
responses and milk virus RNA load in this study (GagRY11:
r=0.36, p=0.31 and EnvKY9: r=0.018, p=0.97). Finally, there
was no correlation between the proportion of milk effector
memory CD8+ T lymphocytes and milk virus RNA load (r=0.08,
p=0.49).
The magnitude of the HIV-specific CD8+ T lymphocyte
responses in milk does not correlate with measures of
breast inflammation
It is well-established that the risk of HIV transmission via
breastfeeding is increased during mastitis [31,42]. Furthermore, the
levels of certain cytokines in milk, including IL-7 [44], IL-8 [33],
RANTES [34,45], and IL-15 [46], have been associated with the
risk of postnatal HIV transmission. It is possible that the local virus-
specific cellular response is impaired during breast inflammation,
contributing to increased risk of infant HIV acquisition. Therefore,
we investigated the relationship between the magnitude of the HIV-
specific CD8+ T lymphocyte response and markers of breast
inflammation. The magnitude of the GagRY11 and EnvKY9-
specific CD8+ T lymphocyte response did not correlate with the
milk sodium:potassium ratio (GagRY11: r=20.19, p=0.11;
Figure 3. Variable relationship between the kinetics of the immunodominant GagRY11-specific CD8+ T cell response in milk (blue
circles) and that in blood (red circles), as well as between the GagRY11-specific CD8+ T cell response in milk and the breast milk
virus RNA load (black triangles) in HIV-infected, lactating women. The plots of GagRY11-specific CD8+ T lymphocyte responses and virus
load in blood (red circles) and milk of left and right breast (blue circles) from each subject are ordered by decreasing proportion of CTL-escaped
plasma virus variants. Milk virus RNA load from each breast (black triangles) is plotted with the GagRY11-specific CD8+ T lymphocyte responses in
each breast.
doi:10.1371/journal.pone.0023735.g003
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GagRY11 and EnvKY9-specific CD8+ T lymphocyte response did
not differ in mastitic (sodium:potassium ratio $1.0) and nonmastitic
(sodium:potassium ratio ,1.0) milk (GagRY11: 0.12% vs 0.67%,
p=0.22; EnvKY9: 0% vs 0.1%, p=0.13). Importantly, there was a
direct correlation between the milk virus RNA load and
sodium:potassium ratio (r=0.41, p=0.004), consistent with similar
findings of high milk virus load during mastitis [30,32].
Finally, we investigated the relationship between the magnitude
of the HIV-specific CD8+ T lymphocyte response in milk and
levels of cytokines previously associated with the risk of postnatal
HIV transmission. There was no correlation between the
magnitude of the GagRY11 or EnvKY9-specific CD8+ T
lymphocyte response and the concentration of RANTES (Ga-
gRY11: r=20.22, p=0.38; EnvKY9: r=0.35, p=0.15), IL-7
(GagRY11: r=20.19, p=0.45; EnvKY9: r=20.08, p=0.76),
IL-8 (GagRY11: r=20.24, p=0.34; EnvKY9: r=20.04,
p=0.89), or IL-15 (GagRY11: r=20.2, p=0.42; EnvKY9:
r=20.3, p=0.23) in milk of each breast collected 4 weeks after
delivery.
Discussion
HIV-specific CD8+ T lymphocyte responses are critical to
control of systemic virus load [12], however, the contribution of
these responses to the control of mucosal virus replication is
unknown. We observed a high proportion of memory CD8+ T
lymphocytes in milk of HIV-infected women and robust HIV-
specific CD8+ T lymphocyte responses in milk. Surprisingly, the
magnitude and kinetics of the HIV-specific CD8+ T lymphocyte
responses in milk were discordant from that in blood and the
contralateral breast, suggesting independent regulation of this
response in each breast compartment. Therefore, the CD8+ T
lymphocyte responses in milk are likely not just a reflection of the
total CD8+ T lymphocyte population in circulation. However, the
discordant kinetics of milk and blood virus-specific CD8+ T
lymphocyte responses could reflect the frequent emptying of the
breast compared to the closed circulatory system.
There are a number of limitations to this study. Due to low
number and viability of cryopreserved milk cells, our character-
ization of the HIV-specific CD8+ T lymphocyte response was
Figure 4. Variable relationship between the kinetics of the subdominant EnvKY9-specific CD8+ T cell response in milk (blue circles)
and that in blood (red circles), as well as between the EnvKY9-specific CD8+ T cell response in milk and the breast milk virus RNA
load (black triangles) in HIV-infected, lactating women. The plots of EnvKY9-specific CD8+ T lymphocyte responses and virus RNA load in
blood (red circles) and milk of left and right breast (blue circles) from each subject are ordered by decreasing proportion of CTL-escaped plasma virus
variants. Milk virus RNA load from each breast (black triangles) is plotted with the EnvKY9-specific CD8+ T lymphocyte responses in each breast.
doi:10.1371/journal.pone.0023735.g004
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Moreover, our subject number was limited to only those HIV-
infected, lactating women in our study with the A*3002 locus.
While the lack of inverse correlation between the systemic A*3002-
restricted HIV-specific cellular immune response and the plasma
virus load could indicate that our power was too limited in this
study to detect a correlation of these parameters in breast milk, we
did identify a significant inverse correlation between the
magnitude of the systemic A*3002-restricted HIV-specific immune
response and the rate of plasma virus CTL escape (r=0.248,
p=0.04). Therefore, the sample size was likely adequate enough
to detect the effect of the immune response on virus control.
Cryopreservation does not seem to differentially affect specific
lymphocyte populations [47,48] or the proportion of virus-specific
CD8+ T lymphocytes (Fig. S1). However, if the HIV-specific
CD8+ T lymphocytes were present in milk at a very low
frequency, this response may not have been detected in our
limited milk cell population. The background tetramer-positive
events detected in the negative controls was very small (one to
three events, ,0.04%), however, the samples with low viable cell
number and low magnitude responses could have been affected by
detection of background tetramer-positive events. Moreover,
assessment of the total HIV-specific CD8+ T lymphocyte response
in milk may have revealed more consistent dynamics of these
responses between milk and blood. Finally, while the only a single
significant correlation was detected between the subdominant
HIV epitope-specific CD8+ T lymphocyte response and the milk
virus RNA load in mature milk (r=0.57, p=0.009), this
significant correlation should be interpreted with caution due to
the multiple comparisons performed with the magnitudes of the
HIV-specific CD8+ T lymphocyte responses in this study.
Our findings of distinct kinetics of the HIV-specific CD8+ T
lymphocyte responses in each breast suggest that the local
immunologic and virologic milieu contributes to the recruitment
or local proliferation of the virus-specific CD8+ T lymphocytes.
However, the magnitude and kinetics of the milk RNA load did
not correlate with this response. Other factors, such as the cell-
associated HIV DNA load and the cytokine milieu in the breast
milk compartment, may contribute to the magnitude of the milk
HIV-specific CD8+ T lymphocyte response. The mechanisms
maintaining virus load in milk that is at least one log lower than in
plasma throughout infection remain to be further explored.
States of breast inflammation [6,28,31] and elevated levels of
certaininflammatorycytokines or chemokines [34,44,45]have been
associated with increased risk of HIV transmission and increased
local virus replication [11,32,34,49]. These associations suggest that
the controlof virus replication maybe impaired by an inflammatory
process in the mammary gland. However, in this small study, there
was not an association between the magnitude of the virus-specific
CD8+ T lymphocyte response and the milk sodium concentration
or the concentration of the inflammatory cytokines proposed to be
associated with virus transmission via breastfeeding.
Despite the lack of correlation between the milk virus RNA load
and HIV-specific CD8+ T lymphocyte response, induction of a
cellular immune response in milk through maternal vaccination
may still be effective at reducing virus transmission via the infant
gastrointestinal tract. There is considerable evidence from animal
models, including primates, that milk lymphocytes are absorbed by
the gastrointestinal tract and confer immunity to the neonate [50–
53],[54]. Further, maternal tuberculin protein-specific delayed
hypersensitivity responses appear to be transferred to infants via
breastfeeding [55–58]. Thus, it is likely that milk lymphocytes play
a role in protection of infants from neonatal pathogens, including
HIV. A study of the HIV-specific CD8+ T lymphocyte responses
in postnatal-transmitting and nontransmitting mothers would
assist in determining if this response is critical for protection of
the breastfeeding infant from HIV acquisition.
Supporting Information
Figure S1 Consistent proportion of epitope-specific
CD8+ T lymphocytes determined by tetramer staining
and flow cytometric analysis of fresh and cryopreserved
breast milk cells of chronically SIV-infected rhesus
monkeys. Dot plots of MamuA*01-restricted SIV Gag p11C
tetramer-staining of fresh and cryopreserved/thawed CD8+ T
lymphocytes isolated from milk of chronically SIV-infected rhesus
monkeys collected four days apart.
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